Thomas Stephen Basil bought CLYM
March 27, 2025 · Form 4 insider transaction
Thomas Stephen Basil bought 25,093 shares of Climb Bio Inc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,093
Price
N/A
Total value
N/A
InsiderThomas Stephen Basil
RoleDirector
CompanyClimb Bio Inc (CLYM)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 27, 2025
Filing dateMarch 27, 2025
Shares owned after179,188
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.